Cargando…

Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area

A serologic test for antibodies to chlamydial antigen pgp3 may be a useful tool for trachoma surveillance. However, little is known about the stability of antibody status over time, or factors associated with seroreversion/conversion. A cohort of 2,111 children ages 1–9 years in Tanzania were follow...

Descripción completa

Detalles Bibliográficos
Autores principales:	West, Sheila K., Munoz, Beatriz, Kaur, Hemjot, Dize, Laura, Mkocha, Harran, Gaydos, Charlotte A., Quinn, Thomas C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824943/ https://www.ncbi.nlm.nih.gov/pubmed/29476106 http://dx.doi.org/10.1038/s41598-018-21127-0

Ejemplares similares

The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020)

Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania
por: Chen, Xinyi, et al.
Publicado: (2022)

Field Evaluation of the Cepheid GeneXpert Chlamydia trachomatis Assay for Detection of Infection in a Trachoma Endemic Community in Tanzania
por: Jenson, Alexander, et al.
Publicado: (2013)

CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs
por: Goodhew, E. Brook, et al.
Publicado: (2012)

The Effect of Multiple Rounds of Mass Drug Administration on the Association between Ocular Chlamydia trachomatis Infection and Follicular Trachoma in Preschool-Aged Children
por: Lee, Jennifer S., et al.
Publicado: (2014)

Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis
por: Zambrano, Andrea I., et al.
Publicado: (2017)

The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study
por: Zambrano, Andrea I., et al.
Publicado: (2016)

Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania
por: West, Sheila K., et al.
Publicado: (2019)

Serological Measures of Trachoma Transmission Intensity
por: Martin, Diana L., et al.
Publicado: (2015)

Risk Factors for Ocular Infection with Chlamydia trachomatis in Children 6 Months following Mass Treatment in Tanzania
por: Cajas-Monson, Luis Carlos, et al.
Publicado: (2011)

Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial
por: West, Sheila K., et al.
Publicado: (2017)

Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey
por: West, Sheila K., et al.
Publicado: (2016)

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania
por: West, Sheila K., et al.
Publicado: (2011)

Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district
por: Odonkor, Michelle, et al.
Publicado: (2021)

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
por: Cama, Anaseini, et al.
Publicado: (2017)

Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration
por: Goodhew, Erica Brook, et al.
Publicado: (2014)

The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma
por: Gwyn, Sarah, et al.
Publicado: (2021)

Trachomatous Scarring and Infection With Non–Chlamydia Trachomatis Bacteria in Women in Kongwa, Tanzania
por: Cox, Jacob T., et al.
Publicado: (2017)

Exposure to an Indoor Cooking Fire and Risk of Trachoma in Children of Kongwa, Tanzania
por: Zambrano, Andrea I., et al.
Publicado: (2015)

The "F" in SAFE: Reliability of assessing clean faces for trachoma control in the field
por: West, Sheila K., et al.
Publicado: (2017)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
por: Liu, Fengchen, et al.
Publicado: (2014)

The Impact of Image Quality and Trachomatous Inflammation on Using Photography for Trachoma Prevalence Surveys
por: Odonkor, Michelle, et al.
Publicado: (2022)

Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds
por: Ssemanda, Elizabeth N., et al.
Publicado: (2012)

Children as messengers of health knowledge? Impact of health promotion and water infrastructure in schools on facial cleanliness and trachoma in the community
por: Chen, Xinyi, et al.
Publicado: (2021)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units
por: Burr, Sarah E., et al.
Publicado: (2019)

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Comparing image quality and trachoma detection across three camera types from a survey in Kongwa, Tanzania
por: Aguwa, Ugochi T, et al.
Publicado: (2023)

Environmental factors and hygiene behaviors associated with facial cleanliness and trachoma in Kongwa, Tanzania
por: Chen, Xinyi, et al.
Publicado: (2021)

Risk factors for the progression of trachomatous scarring in a cohort of women in a trachoma low endemic district in Tanzania
por: Wolle, Meraf A., et al.
Publicado: (2021)

Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
por: Liu, Fengchen, et al.
Publicado: (2013)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
por: Liu, Fengchen, et al.
Publicado: (2013)

Trachoma Prevalence and Associated Risk Factors in The Gambia and Tanzania: Baseline Results of a Cluster Randomised Controlled Trial
por: Harding-Esch, Emma M., et al.
Publicado: (2010)

Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3
por: Gwyn, Sarah, et al.
Publicado: (2017)

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
por: Hu, Victor H., et al.
Publicado: (2013)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_p068m6gv3o7cppk7hbml2srihu